Burning Rock Biotech Limited (BNR)

Burning Rock Biotech Revenue

In the year 2023, Burning Rock Biotech had annual revenue of $75.80M, a decrease of -6.20%. Revenue in the quarter ending December 31, 2023 was $17.08M, a -16.31% decrease year-over-year.

• Revenue (ttm): $75.80M
• Revenue Growth: -6.20%
• P/S Ratio: 1.13
• Revenue / Employee: $96,440
• Employees: 786
• Market Cap: 85.28M USD

Revenue Chart

* The company reports in CNY currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	75.80M	-5.01M	-6.20%
Dec 31, 2022	80.81M	1.46M	1.83%
Dec 31, 2021	79.35M	13.62M	20.72%
Dec 31, 2020	65.73M	11.21M	20.56%
Dec 31, 2019	54.53M	24.30M	80.39%
Dec 31, 2018	30.23M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.